Xiaohu Zheng

Title: Innovations of Xiaohu Zheng in Antibody Development

Introduction

Xiaohu Zheng is a prominent inventor based in Hefei, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic use. His innovative work focuses on creating antibodies that can target specific proteins associated with tumors.

Latest Patents

Xiaohu Zheng holds a patent for an "Antibody or antibody fragment capable of binding to lung-specific X protein and use thereof." This patent describes an antibody or antibody fragment that can bind to a lung-specific X protein, which is crucial for treating tumors. The invention includes heavy chain CDRs with specific amino acid sequences and light chain CDRs that enhance the antibody's effectiveness. The antibody is characterized as a chimeric antibody, showcasing Zheng's expertise in antibody engineering.

Career Highlights

Zheng is affiliated with the Immunopharmaceutic Institute of Hefei Ruida Co., Ltd., where he continues to advance his research in antibody development. His work has led to the creation of innovative therapeutic solutions that have the potential to improve cancer treatment outcomes.

Collaborations

Zheng collaborates with notable colleagues, including Zhigang Tian and Rui Sun. Their combined expertise contributes to the advancement of research in the field of immunopharmaceuticals.

Conclusion

Xiaohu Zheng's contributions to antibody development represent a significant advancement in biotechnology. His innovative patent and ongoing research efforts highlight the potential for new therapeutic approaches in treating tumors.